BioLargo Files 8-K on Security Holder Vote & Exhibits
Ticker: BLGO · Form: 8-K · Filed: Jun 20, 2024 · CIK: 880242
Sentiment: neutral
Topics: corporate-governance, filing
Related Tickers: BLGO
TL;DR
BioLargo's voting on key issues, check the exhibits for details.
AI Summary
On June 13, 2024, BioLargo, Inc. filed an 8-K report detailing the submission of matters to a vote of security holders. The filing also includes financial statements and exhibits, though specific details of the vote or financial performance are not elaborated in the provided text.
Why It Matters
This filing indicates important corporate actions are being put to a shareholder vote, which could impact the company's future direction and governance.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose immediate financial distress or significant operational changes.
Key Players & Entities
- BioLargo, Inc. (company) — Registrant
- June 13, 2024 (date) — Earliest event reported
FAQ
What specific matters are being submitted to a vote of BioLargo's security holders?
The provided text states that matters are being submitted to a vote of security holders, but does not specify what those matters are.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 13, 2024.
What is BioLargo, Inc.'s state of incorporation?
BioLargo, Inc. is incorporated in Delaware.
What is BioLargo, Inc.'s principal executive office address?
BioLargo, Inc.'s principal executive office is located at 14921 Chestnut St., Westminster, California 92683.
What other items are included in this 8-K filing besides the submission of matters to a vote?
This 8-K filing also includes Financial Statements and Exhibits.
Filing Stats: 676 words · 3 min read · ~2 pages · Grade level 9.3 · Accepted 2024-06-20 13:55:32
Filing Documents
- blgo20240619_8k.htm (8-K) — 53KB
- 0001437749-24-020750.txt ( ) — 180KB
- blgo-20240613.xsd (EX-101.SCH) — 3KB
- blgo-20240613_def.xml (EX-101.DEF) — 11KB
- blgo-20240613_lab.xml (EX-101.LAB) — 14KB
- blgo-20240613_pre.xml (EX-101.PRE) — 11KB
- blgo20240619_8k_htm.xml (XML) — 3KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders BioLargo, Inc. (the "Company") held its 2024 annual stockholder meeting on June 13, 2024. The following proposals were each submitted to a vote of stockholders through the solicitation of proxies or otherwise: 1. A proposal to elect the following seven individuals to the Company's Board of Directors: Dennis P. Calvert, Kenneth R. Code, Dennis E. Marshall, Joseph L. Provenzano, Jack B. Strommen, Linda Park, and Christina Bray; 2. A proposal to approve, on an advisory basis, the compensation of the Company's named executive officers; 3. A proposal to ratify the appointment of Hacker Johnson & Smith PA as the Company's independent registered public accounting firm for the year ending December 31, 2024; and 4. A proposal to adopt the 2024 Equity Incentive Plan. A quorum was present in person or by proxy. There were no director nominees other than as set forth above. Each director was elected to the Company's Board of Directors, and each of proposals 2, 3 and 4 were approved, in accordance with Delaware law and the Company's bylaws. The voting results are as follows: Proposal One Votes For Votes Withheld Broker Non-Vote Dennis P. Calvert 95,973,191 2,531,303 75,196,191 Kenneth R. Code 97,016,500 1,487,994 75,196,191 Dennis E. Marshall 96,713,705 1,790,789 75,196,191 Joseph L. Provenzano 96,906,120 1,598,374 75,196,191 Jack B. Strommen 96,916,500 1,587,994 75,196,191 Linda Park 96,928,400 1,576,094 75,196,191 Christina Bray 96,800,400 1,704,094 75,196,191 Proposals 2 - 4 Votes For Votes Against Votes Abstain Broker Non-Vote Percentage "for" 2 94,165,357 3,453,224 885,913 75,196,191 96.5% 3 170,877,497 1,891,556 931,632 - 98.9% 4 170,877,497 1,891,556 931,632 - 98.9% For the proposals to approve, on an advisory basis, the compensation of the Company's named executive officers, prior year votes are as follows: Year Votes For Vote
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 20, 2024 BIOLARGO, INC. By: /s/ Dennis P. Calvert Dennis P. Calvert President and Chief Executive Officer